Senior Director, Market Access, Spain en Cepsa

Cepsa es una multinacional española de energía con operaciones en refino, química, gas y energías renovables. Empresa de 3.000+ empleados que contrata continuamente técnicos, operarios e ingenieros.

Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) …

Si estás interesado en trabajar como Senior Director, Market Access, Spain en Cepsa, accede al portal oficial para completar tu candidatura.